Israeli coronavirus mutation discovered in the country

AuthorMAAYAN JAFFE-HOFFMAN
Published date30 March 2021
Date30 March 2021
Publication titleJerusalem Post, The: Web Edition Articles (Israel)
"The Israeli variant appeared in samples from July but is disappearing and the evidence for it is dwindling," the ministry said in a statement, two days after scientists from Israel's Central Virology Laboratory posted a paper about the mutation on MedRxiv.

In the report, it explains that the strain, which began circulating in July, was first identified in wastewater sequencing in October 2020 and then in clinical samples for the first time in November 2020.

In October 2020, it was found at a 5% frequency in wastewater samples from the southern Israeli city of Rahat. In November, the strain was discovered at a frequency of 98% in Netanya and Haifa.

So far, some 181 people are known to have been infected with the mutation, according to the paper, but health officials believe there could be hundreds more who were infected with the virus.

Nonetheless, the British variant remains the dominant strain in Israel, still constituting at least 90% of all cases.

The strain has not been associated with higher infection rates nor does it appear to cause more serious illness. Furthermore, the Pfizer vaccine appears effective against it.

The variant was discovered by the Central Virology Laboratory at Sheba Medical Center, Tel Hashomer, during routine genetic sequencing. The ministry said it has "no clinical or epidemiological significance."

"There is nothing new and nothing worrying here," Prof. Eyal Leshem, director of Sheba's Center for Travel Medicine and Tropical Diseases, told The Jerusalem Post.

He also noted that the less transmission there is in Israel and the higher the immunization rate, the less concerned the country needs to be about new local variants. However, he said that Israel must...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT